Prima's cancer research earns a tick from Alpha
Print CITY BEAT: Rebecca Urban | July 03, 2009
Article from: The Australian
REGULAR users of internet chat forums have been inspired by the latest research report on cancer drug hopeful Prima Biomed.
Boutique broking and adviser Alpha Securities has penned a few words on the Melbourne biotech that has won backing from Lucy Turnbull and former television executive turned investor Laurence Freedman.
Alpha reckons the company's establishment of a
$12 million facility earlier this year has largely addressed its funding risk and will ensure that its pivotal phase II and III trials can go ahead.
"The company had initially expected to conduct trials on 340 patients over three tranches, although based on discussions with the (US Food and Drug Administration), the company may only need to conduct a randomised 60-patient trial," the report says. "The trial is likely to require 15 sites in the US and 15 sites in Australia and New Zealand."
"An excellent read," posted one particularly enthusiastic blogger.
We assume it's an accurate read, too, given Alpha's cosy relationship with Prima.
Alpha entered into an $80,000 consultancy agreement with Prima in April, with a mandate to promote the company.
Good to see that it is busy earning the two million shares it has since acquired in lieu of cash.
- Forums
- ASX - By Stock
- today's australian
Prima's cancer research earns a tick from Alpha Print CITY BEAT:...
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
47.0¢ |
Change
0.035(8.05%) |
Mkt cap ! $558.7M |
Open | High | Low | Value | Volume |
44.5¢ | 48.5¢ | 44.5¢ | $2.743M | 5.852M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 55686 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 39074 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 55686 | 0.460 |
4 | 84490 | 0.455 |
5 | 316816 | 0.450 |
3 | 76298 | 0.445 |
5 | 43638 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 39074 | 1 |
0.475 | 29220 | 1 |
0.480 | 312143 | 8 |
0.485 | 101598 | 12 |
0.490 | 114920 | 19 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
46.5¢ |
  |
Change
0.035 ( 6.90 %) |
|||
Open | High | Low | Volume | ||
45.0¢ | 48.5¢ | 45.0¢ | 1500168 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
IMM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online